Keyphrases
Candida Albicans (C. albicans)
90%
C.albicans
57%
Candida
28%
Chitin
27%
Candidiasis
24%
Amphotericin B
22%
Fungi
20%
Adhesion
19%
Epithelial Cells
18%
Vaccination
17%
Intralipid
16%
Soluble Extract
15%
Candida Species
12%
Dermatophytes
11%
Chronic mucocutaneous Candidiasis
11%
Nystatin
10%
Aspergillosis
9%
Inoculation
9%
Medical Mycology
9%
Sand
9%
Survival Rate
8%
Nystatin-Intralipid
8%
Guinea pig
7%
Ocular Infection
7%
Immunization
7%
Cyclophosphamide
7%
Buccal Epithelial Cells
7%
Polyenes
7%
Beach Sand
7%
Intestinal mucosa
7%
Aspergillus Terreus
7%
Candida Infection
7%
HepG2 Cells
7%
Immune Response
6%
Cell Effects
6%
Candida Vaginitis
6%
Yeast Infection
6%
ISHAM
6%
International Guidelines
6%
Chitin Derivatives
6%
Vaginal Epithelial Cells
6%
Clinical Entities
6%
5-fluorocytosine
6%
Mean Survival Time
6%
Nucleic Acids
6%
Aspergillus Spp
6%
Human Vaginal Epithelial Cells
5%
Antifungal Therapy
5%
Experimental Candidiasis
5%
Invasive Candidiasis
5%
Immunology and Microbiology
Candida Albicans
100%
Candida
34%
Mould
16%
Aspergillus
14%
Dermatophyte
13%
Infectious Agent
12%
Vaginitis
9%
Cyclophosphamide
9%
Medical Mycology
9%
Survival Time
9%
Survival Rate
8%
Murine
7%
Colony-Forming Unit
7%
Guinea Pig
7%
Immune Response
7%
Mycology
6%
Institute for Cancer Research Mouse
6%
Adoptive Immunity
6%
Scanning Electron Microscopy
5%
Microorganism
5%
Fungal Cell
5%
Gastrointestinal Mucosa
5%
Pharmacology, Toxicology and Pharmaceutical Science
Candida Albicans
39%
Infection
26%
Candida
24%
Intralipid
23%
Amphotericin B
22%
Candidiasis
18%
Chitin
15%
Nystatin
13%
Infectious Agent
12%
Eye Infection
7%
Invasive Candidiasis
7%
Polyene
7%
Aspergillus
6%
Vaginitis
6%
Diseases
6%
Dermatophyte
5%
Mould
5%
Experimental Candidiasis
5%
Cyclophosphamide
5%
Flucytosine
5%
Microorganism
5%
Survival Time
5%
Antifungal Activity
5%
Caspofungin
5%
Murine
5%